{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:29:35Z","timestamp":1787027375408,"version":"build-2736575974"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl. Int."],"abstract":"<jats:p>ABO-incompatible (ABOi) kidney transplantation carries a high risk of acute antibody-mediated rejection due to the presence of isoagglutinins. To mitigate this risk, current protocols recommend performing apheresis before transplantation. Our objective was to evaluate outcomes in ABOi recipients with low isoagglutinin titers, comparing those who did and did not undergo pre-transplant apheresis. We conducted a multicenter study including recipients of ABOi kidney transplants between 2012 and 2022. A total of 78 patients with baseline isoagglutinin titers \u22641:8 were included; 41 received pre-transplant apheresis, 37 did not. Patients who did not undergo apheresis had more rejection episodes (p = 0.01), and a trend toward higher rates of delayed graft function and antibody mediated rejection, which adversely impacted patient and graft survival. At 3 years, event-free survival (death or graft loss) was 90% in the apheresis versus 79% in the no-apheresis group (p = 0.02). In multivariable analysis, factors associated with improved event-free survival included pre-transplant apheresis (HR = 0.31, p = 0.049) while ABMR within the first month was associated with poorer outcome (HR = 5.18, p = 0.0007). No differences emerged regarding the occurrence of overall infections. These findings suggest that apheresis should be systematically performed prior to ABOi transplantation, regardless of baseline isoagglutinin titer.<\/jats:p>","DOI":"10.3389\/ti.2026.16059","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:10:05Z","timestamp":1779772205000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["ABO-incompatible kidney transplantation: impact of apheresis on graft and patient survival in recipients with low isoagglutinin titer"],"prefix":"10.3389","volume":"39","author":[{"given":"Marion","family":"Mangin","sequence":"first","affiliation":[{"name":"Department of Nephrology Dialysis and Transplantation, Strasbourg University Hospital","place":["Strasbourg, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Lucas","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital","place":["Bordeaux, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Taton","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital","place":["Bordeaux, France"]},{"name":"INSERM U1219 Bordeaux Population Health, Equipe LEHA, Bordeaux University","place":["Bordeaux, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dany","family":"Anglicheau","sequence":"additional","affiliation":[{"name":"Department of Kidney and Metabolic Diseases, Transplantation and Clinical Immunology, Necker Hospital, Assistance Publique - H\u00f4pitaux de Paris, Universit\u00e9 Paris Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Blancho","sequence":"additional","affiliation":[{"name":"CHU Nantes, Nantes Universit\u00e9, Service de N\u00e9phrologie - Immunologie Clinique, ITUN, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064","place":["Nantes, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bertrand","sequence":"additional","affiliation":[{"name":"Nephrology and Transplantation Department, Rouen University Hospital","place":["Rouen, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Leon","sequence":"additional","affiliation":[{"name":"Department of Kidney and Metabolic Diseases, Transplantation and Clinical Immunology, Necker Hospital, Assistance Publique - H\u00f4pitaux de Paris, Universit\u00e9 Paris Cit\u00e9","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jo\u00eblle","family":"Apithy","sequence":"additional","affiliation":[{"name":"Etablissement Francais du Sang Grand Est","place":["Strasbourg, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilies","family":"Benotmane","sequence":"additional","affiliation":[{"name":"Department of Nephrology Dialysis and Transplantation, Strasbourg University Hospital","place":["Strasbourg, France"]},{"name":"Molecular ImmunoRhumatology, INSERM UMR_S1109, Strasbourg University","place":["Strasbourg, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Couzi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital","place":["Bordeaux, France"]},{"name":"CNRS-UMR 5164 ImmunoConcEpT, Bordeaux University","place":["Bordeaux, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Caillard","sequence":"additional","affiliation":[{"name":"Department of Nephrology Dialysis and Transplantation, Strasbourg University Hospital","place":["Strasbourg, France"]},{"name":"Molecular ImmunoRhumatology, INSERM UMR_S1109, Strasbourg University","place":["Strasbourg, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/TP.0000000000000312","article-title":"Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed ayer ABO antibody reduction: results from 101 centers","volume":"99","author":"Opelz","year":"2015","journal-title":"Transplantation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000535583","article-title":"Outcomes of ABO-incompatible living donor kidney transplantation compared to waiting or deceased donor kidney transplantation","volume":"55","author":"Koo","year":"2024","journal-title":"Am J Nephrol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(18)32091-9","article-title":"Clinical outcomes ayer ABO-Incompatible renal transplantation: a systematic review and meta-analysis","volume":"393","author":"Scurt","year":"2019","journal-title":"The Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2215\/CJN.00540118","article-title":"ABO-incompatible kidney transplant outcomes: a meta-analysis","volume":"13","author":"De Weerd","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.ekir.2024.12.031","article-title":"Early thrombotic microangiopathy after ABO-incompatible living donor kidney transplantation","volume":"10","author":"Bertrand","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/01.tp.0000173647.43616.78","article-title":"Lack of correlation between results of ABO-incompatible living kidney transplantation and Anti-ABO blood type antibody titers under our current immunosuppression","volume":"80","author":"Shimmura","year":"2005","journal-title":"Transplantation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/trf.15672","article-title":"ABO-incompatible kidney transplantation can be successfully conducted by monitoring IGM isoagglutinin titers during desensibilisation","volume":"60","author":"Kim","year":"2020","journal-title":"Transfusion"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1111\/ajt.12920","article-title":"ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone","volume":"14","author":"Masterson","year":"2014","journal-title":"Am J Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/TP.0b013e318245b2af","article-title":"Outcomes of ABO-incompatible kidney transplantation in the United States","volume":"93","author":"Montgomery","year":"2012","journal-title":"Transplantation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/tri.12234","article-title":"Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation","volume":"27","author":"Barnett","year":"2014","journal-title":"Transpl Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.transproceed.2015.08.021","article-title":"Desensitization in ABO-incompatible kidney transplantation with low ABO iso-agglutinin titers","volume":"47","author":"Gelpi","year":"2015","journal-title":"Transplant Proc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/iju.14944","article-title":"Outcome of ABO-Incompatible kidney transplantation using a modified desensibilisation protocol without plasmapheresis","volume":"29","author":"Shinoda","year":"2022","journal-title":"Int J Urol Sept"},{"key":"B13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00467-019-04376-7","article-title":"ABO-incompatible pediatric kidney transplantation without antibody removal","volume":"35","author":"Kawamura","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1111\/tri.14145","article-title":"ABO-incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity-matched analysis","volume":"34","author":"De Weerd","year":"2021","journal-title":"Transpl Int"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1097\/01.TP.0000438210.27218.9e","article-title":"No progress in ABO titer measurement: time to aim for a reference?","volume":"97","author":"Bentall","year":"2014","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1111\/ajt.16712","article-title":"Characterization of ABH-subtype donor-specific antibodies in ABO-A-incompatible kidney transplantation","volume":"21","author":"Bentall","year":"2021","journal-title":"Am J Transpl"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15171\/jnp.2016.04","article-title":"Early post-transplant complications following ABO-incompatible kidney transplantation","volume":"5","author":"Naciri","year":"2016","journal-title":"J Nephropathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/TP.0000000000000029","article-title":"Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients","volume":"98","author":"Lentine","year":"2014","journal-title":"Transplantation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1093\/ndt\/gfr215","article-title":"Increase of infectious complications in ABO-incompatible kidney transplant recipients \u2013 a single centre experience","volume":"26","author":"Habicht","year":"2011","journal-title":"Nephrol Dial Transpl"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1093\/ndt\/gfq229","article-title":"Longterm outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis","volume":"25","author":"Wilpert","year":"2010","journal-title":"Nephrol Dial Transpl"},{"key":"B21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.21037\/tau-24-617","article-title":"Evaluation of different methods for antibody titre determination in ABO-incompatible kidney transplantation","volume":"14","author":"Zhou","year":"2025","journal-title":"Transl Androl Urol"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2026.16059\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:10:07Z","timestamp":1779772207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2026.16059\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":21,"alternative-id":["10.3389\/ti.2026.16059"],"URL":"https:\/\/doi.org\/10.3389\/ti.2026.16059","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"16059"}}